MYCN and neuroblastoma: Finally, the utility of the 3-channel/3-animal RF coil for performing pre-clinical interventional trials at 3T was investigated by assessing the anatomical and functional MRI response of tumours arising in Th-MYCN transgenic mice to CPM, the current standard treatment of care for children with high-risk neuroblastoma, or CBZ, currently in clinical trials for the treatment of neuroblastoma.